NATURE'S MIRCLE HLDG WTS (NMHIW) Financials
Newest figures come from the 10-Q for Q1 FY2026, filed May 27, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the NMHIW SEC filings page.
NATURE'S MIRCLE HLDG WTS (NMHIW) reported $677K in revenue over the twelve months to Mar 31, 2026, down 91.7% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Shrinking scale is the dominant mechanic: a loss-making operation with a weak working-capital position increasingly depends on external financing.
Revenue contraction from$9.3M in FY2024 to$1.7M in FY2025 did not bring the business toward gross-profit break-even. Gross margin stayed negative at-30.3% and-25.9% , indicating unresolved cost economics rather than a simple temporary earnings drag.
The balance sheet tightened faster than the income statement: current ratio fell from 0.5x in FY2023 to 0.0x in FY2025, while FY2025 liabilities exceeded assets. That combination indicates a very thin short-term buffer alongside negative book equity, rather than merely an income loss.
Operating cash flow was
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of NATURE'S MIRCLE HLDG WTS's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
NATURE'S MIRCLE HLDG WTS held $98K in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $4.0M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and NATURE'S MIRCLE HLDG WTS scores 2/100 among other emerging companies.
NATURE'S MIRCLE HLDG WTS had 349M shares outstanding at the end of fiscal year 2025. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and NATURE'S MIRCLE HLDG WTS scores 5/100 among other emerging companies.
Not available for NATURE'S MIRCLE HLDG WTS, and counted as zero in the overall score.
NATURE'S MIRCLE HLDG WTS reported revenue of $1.7M in fiscal year 2025, against $9.3M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and NATURE'S MIRCLE HLDG WTS scores 4/100 among other emerging companies.
NATURE'S MIRCLE HLDG WTS's operations used $4.0M of cash in fiscal year 2025, against $5.9M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and NATURE'S MIRCLE HLDG WTS scores 15/100 among other emerging companies.
NATURE'S MIRCLE HLDG WTS's cash, cash equivalents and investments came to $98K at the end of fiscal year 2025, against $31.7M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and NATURE'S MIRCLE HLDG WTS scores 1/100 among other emerging companies.
NATURE'S MIRCLE HLDG WTS passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
NATURE'S MIRCLE HLDG WTS reported a net loss of $12.0M while operations used $4.0M of cash. With neither figure positive, the ratio between the two carries no quality signal.
NATURE'S MIRCLE HLDG WTS reported an operating loss of $7.2M against $628K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
NATURE'S MIRCLE HLDG WTS generated $42K in revenue in Q1 2026. This represents a decrease of 96.2% from the same quarter a year earlier. Against the prior quarter it is down 47.4%.
NATURE'S MIRCLE HLDG WTS's EBITDA was -$942K in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 16.0% from the same quarter a year earlier. Against the prior quarter it is up 71.5%.
NATURE'S MIRCLE HLDG WTS reported $2.8M in net income in Q1 2026. This represents an increase of 240.9% from the same quarter a year earlier. Against the prior quarter it is up 147.5%.
NATURE'S MIRCLE HLDG WTS earned $0.01 per diluted share (EPS) in Q1 2026. It is unchanged from the prior quarter.
Cash & Balance Sheet
NATURE'S MIRCLE HLDG WTS recorded an outflow of $2.6M in free cash flow in Q1 2026, representing a cash shortfall after capex.
NATURE'S MIRCLE HLDG WTS held $46K in cash against $7.4M in long-term debt as of Q1 2026.
Not reported for Q1 2026.
Margins & Returns
NATURE'S MIRCLE HLDG WTS's gross margin was 7.0% in Q1 2026, indicating the percentage of revenue retained after direct costs. This is down 8.8 percentage points from the same quarter a year earlier.
Not shown for Q1 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q1 2026: the reported ratio is above 100.0% of revenue, so it does not read as a share of revenue.
Not reported for Q1 2026.
Capital Allocation
NATURE'S MIRCLE HLDG WTS invested $1.0M in capex in Q1 2026, funding long-term assets and infrastructure.
Not reported for Q1 2026.
Not reported for Q1 2026.
NMHIW Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $42K-96.2% | $79K-86.8% | $72K-97.6% | $484K-85.8% | $1.1M-49.8% | $599K-55.0% | $3.1M+13.5% | $3.4M+75.2% |
| Cost of Revenue | $39K-95.8% | $735K-83.3% | $72K-97.5% | $455K-84.6% | $932K-50.8% | $4.4M+55.0% | $2.8M+11.6% | $3.0M+60.2% |
| Gross Profit | $3K-98.3% | -$656K+82.7% | $426-99.8% | $29K-93.6% | $175K-43.9% | -$3.8M-152.3% | $228K+43.7% | $452K+351.0% |
| SG&A Expenses | $1.1M-17.0% | $1.3M-29.5% | $1.2M-44.9% | $1.0M-40.5% | $1.3M-0.9% | $1.9M+21.4% | $2.2M+277.2% | $1.7M+276.1% |
| Operating Income | -$1.1M+6.3% | -$3.5M+42.2% | -$1.3M+33.3% | -$1.2M+10.3% | -$1.2M-15.8% | -$6.1M-21.3% | -$2.0M-373.9% | -$1.3M-259.1% |
| EBITDA | -$942K+16.0% | -$3.3M+45.2% | -$1.3M+32.8% | -$1.1M+10.6% | -$1.1M-16.4% | -$6.0M-21.5% | -$2.0M-415.5% | -$1.2M-293.8% |
| Interest Expense | $781K-13.0% | -$1.5M-10.4% | $595K-19.4% | $606K+24.6% | $897K+196.6% | -$1.3M-445.9% | $738K+2036.9% | $487K+1585.4% |
| Income Tax | N/A | N/A | N/A | N/A | $2K0.0% | N/A | N/A | $800+100.6% |
| Net Income | $2.8M+240.9% | -$6.0M+12.3% | -$2.2M+19.8% | -$1.8M-0.1% | -$2.0M+12.4% | -$6.8M-14.6% | -$2.8M-580.8% | -$1.8M-334.9% |
| EPS (Basic) | $0.02+104.7% | $0.01+100.2% | -$0.20+92.7% | -$0.29+85.6% | -$0.43+85.6% | -$4.19+57.3% | -$2.73-13550.0% | -$2.01-9950.0% |
| EPS (Diluted) | $0.01 | $0.01+100.2% | -$0.20 | -$0.29 | -$0.43 | -$4.19 | -$2.73 | -$2.01 |
| Diluted Shares (Avg) | 270M | N/A | 11M | 6M | 5M | N/A | 1M | 880,467 |
Not reported in any period shown, so not listed: R&D Expenses.
NMHIW Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $21.5M+119.0% | $20.4M+80.4% | $23.0M+65.6% | $9.1M-31.7% | $9.8M-18.2% | $11.3M-20.3% | $13.9M | $13.3M |
| Current Assets | $1.3M-64.0% | $956K-81.5% | $3.2M-59.8% | $2.8M-61.2% | $3.5M-43.9% | $5.2M-30.3% | $8.0M | $7.3M |
| Cash & Equivalents | $46K+158.9% | $98K-76.7% | $61K+53.2% | $10K-68.8% | $18K-94.1% | $420K+89.5% | $40K-94.5% | $31K-97.8% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | N/A | N/A | $639K-80.8% | $703K-83.1% | $867K-81.4% | $1.8M-64.8% | $3.3M | $4.2M |
| Accounts Receivable | $146K-91.6% | $153K-91.6% | $1.2M-48.6% | $1.4M-29.7% | $1.7M+107.3% | $1.8M+48.0% | $2.4M | $2.1M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $29.3M+16.2% | $31.7M+23.6% | $31.6M+22.7% | $26.0M-1.3% | $25.2M+7.1% | $25.7M+22.6% | $25.7M | $26.4M |
| Current Liabilities | $18.9M-3.0% | $23.3M+17.6% | $23.0M+16.4% | $20.4M0.0% | $19.5M+10.6% | $19.8M+33.7% | $19.7M | $20.4M |
| Non-Current Liabilities | $10.4M+80.7% | $8.4M+43.4% | $8.6M+43.4% | $5.7M-5.9% | $5.8M-3.3% | $5.9M-4.1% | $6.0M | $6.0M |
| Long-Term Debt | $7.4M+32.6% | $5.4M-4.9% | $5.4M-5.6% | $5.5M-5.4% | $5.6M-5.2% | $5.7M-5.0% | $5.8M | $5.8M |
| Total Equity | -$9.3M+39.9% | -$12.7M+11.1% | -$9.4M+21.8% | -$17.0M-28.0% | -$15.4M-31.8% | -$14.3M-113.4% | -$12.0M-1475.2% | -$13.3M-3627.9% |
| Retained Earnings | -$34.0M-27.0% | -$36.8M-48.8% | -$30.7M-73.0% | -$28.5M-89.8% | -$26.8M-101.8% | -$24.7M-199.9% | -$17.8M | -$15.0M |
Not reported in any period shown, so not listed: Goodwill.
NMHIW Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.6M-170.2% | -$2.2M+21.1% | -$896K+37.2% | -$315K+67.5% | -$594K+23.2% | -$2.8M-220.4% | -$1.4M-345.9% | -$969K-1427.2% |
| Depreciation & Amortization | $146K+266.4% | $206K+416.7% | $18K-55.7% | $40K0.0% | $40K0.0% | $40K0.0% | $40K-4.4% | $40K-4.4% |
| Stock-Based Compensation | $105K+23.4% | N/A | $84K-90.1% | $61K-68.9% | $85K-50.6% | N/A | $848K | $196K |
| Capital Expenditures | $1.0M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | -$2.6M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$1.0M-233.3% | $0 | -$142K | -$421K | -$300K-650.0% | $0+100.0% | $0+100.0% | $0+100.0% |
| Financing Cash Flow | $2.6M+419.8% | $2.2M-29.5% | $1.1M-24.1% | $728K+4.0% | $491K-44.9% | $3.1M+480.7% | $1.4M+1933.5% | $700K-40.6% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
NMHIW Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 7.0%-8.8pp | -828.4% | 0.6%-6.9pp | 6.0%-7.3pp | 15.8%+1.7pp | -633.9% | 7.5%+1.6pp | 13.3%+8.1pp |
| Operating Margin | -2614.7% | -4430.6% | -1839.7% | -238.2% | -104.9% | -1012.3% | -65.4%-49.7pp | -37.7%-19.3pp |
| Net Margin | 6838.8% | -7566.4% | -3049.1% | -365.9% | -182.5% | -1139.6% | -90.1%-75.1pp | -51.9%-31.0pp |
| Return on Assets | 13.2%+33.8pp | -29.3%+31.0pp | -9.6%+10.2pp | -19.6%-6.2pp | -20.5%-1.3pp | -60.4%-18.4pp | -19.8% | -13.3% |
| Current Ratio | 0.07-0.1x | 0.04-0.2x | 0.14-0.3x | 0.14-0.2x | 0.18-0.2x | 0.26-0.2x | 0.41 | 0.36 |
| Asset Turnover | 0.00-0.1x | 0.000.0x | 0.00-0.2x | 0.05-0.2x | 0.11-0.1x | 0.050.0x | 0.22 | 0.26 |
| FCF Margin | -6262.7% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin, Operating Margin, Net Margin, FCF Margin.
Note: Shareholder equity is negative (-$12.7M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.04), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| NATURE'S MIRCLE HLDG WTS NMHIW | FY2025 | $1.7M | -$12.0M | N/A | N/A | 5/100 |
| Clean Energy Technologies, Inc. CETY | FY2025 | $2.2M | -$6.8M | N/A | $12.1M | 9/100 |
| INLIF LIMITED INLF | FY2025 | $18.4M | -$5.4M | -29.6% | $2.9M | 42/100 |
| Laser Photonics Corporation LASE | FY2025 | $8.3M | -$17.5M | N/A | $53.8M | 27/100 |
| Li Bang International Corporation Inc. LBGJ | FY2025 | $11.1M | -$1.0M | -9.1% | $1.2M | 22/100 |
| CVD Equipment Corp. CVV | FY2025 | $25.8M | -$1.6M | -6.2% | $31.8M | 49/100 |
Where NATURE'S MIRCLE HLDG WTS Ranks
Frequently Asked Questions
What is NATURE'S MIRCLE HLDG WTS's annual revenue?
NATURE'S MIRCLE HLDG WTS (NMHIW) reported $1.7M in total revenue for fiscal year 2025. This represents a -81.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is NATURE'S MIRCLE HLDG WTS's revenue growing?
NATURE'S MIRCLE HLDG WTS (NMHIW) revenue declined by 81.2% year-over-year, from $9.3M to $1.7M in fiscal year 2025.
Is NATURE'S MIRCLE HLDG WTS profitable?
No, NATURE'S MIRCLE HLDG WTS (NMHIW) reported a net income of -$12.0M in fiscal year 2025.
What is NATURE'S MIRCLE HLDG WTS's EBITDA?
NATURE'S MIRCLE HLDG WTS (NMHIW) had EBITDA of -$6.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does NATURE'S MIRCLE HLDG WTS have?
As of fiscal year 2025, NATURE'S MIRCLE HLDG WTS (NMHIW) had $98K in cash and equivalents against $5.4M in long-term debt.
What is NATURE'S MIRCLE HLDG WTS's gross margin?
NATURE'S MIRCLE HLDG WTS (NMHIW) had a gross margin of -25.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is NATURE'S MIRCLE HLDG WTS's operating cash flow?
NATURE'S MIRCLE HLDG WTS (NMHIW) recorded an outflow of $4.0M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are NATURE'S MIRCLE HLDG WTS's total assets?
NATURE'S MIRCLE HLDG WTS (NMHIW) had $20.4M in total assets as of fiscal year 2025, including both current and long-term assets.
What is NATURE'S MIRCLE HLDG WTS's current ratio?
NATURE'S MIRCLE HLDG WTS (NMHIW) had a current ratio of 0.04 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is NATURE'S MIRCLE HLDG WTS's return on assets (ROA)?
NATURE'S MIRCLE HLDG WTS (NMHIW) had a return on assets of -58.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
How does NATURE'S MIRCLE HLDG WTS's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, NATURE'S MIRCLE HLDG WTS (NMHIW) held $98K in cash, cash equivalents and investments, and reported an operating cash outflow of $4.0M over that year. Dividing the one by the other, the reported balance equals about 0 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Why is NATURE'S MIRCLE HLDG WTS's debt-to-equity ratio negative or not reported?
NATURE'S MIRCLE HLDG WTS (NMHIW) has negative shareholder equity of -$12.7M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is NATURE'S MIRCLE HLDG WTS's Piotroski F-Score?
NATURE'S MIRCLE HLDG WTS (NMHIW) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are NATURE'S MIRCLE HLDG WTS's earnings high quality?
NATURE'S MIRCLE HLDG WTS (NMHIW) reported a net loss of $12.0M while operations used $4.0M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can NATURE'S MIRCLE HLDG WTS cover its interest payments?
NATURE'S MIRCLE HLDG WTS (NMHIW) reported an operating loss of $7.2M against $628K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is NATURE'S MIRCLE HLDG WTS?
NATURE'S MIRCLE HLDG WTS (NMHIW) scores 5 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.